Response to a letter to the editor regarding ' the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka'
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_8f04560e2ae24d55bbff3ccb486a93e1 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Zumrut Sahbudak Bal |e author |
| 700 | 1 | 0 | |a Aysin Zeytinoglu |e author |
| 700 | 1 | 0 | |a Ferda Ozkinay |e author |
| 700 | 1 | 0 | |a Zafer Kurugol |e author |
| 245 | 0 | 0 | |a Response to a letter to the editor regarding ' the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka' |
| 260 | |b Taylor & Francis Group, |c 2022-11-01T00:00:00Z. | ||
| 500 | |a 2164-5515 | ||
| 500 | |a 2164-554X | ||
| 500 | |a 10.1080/21645515.2022.2073760 | ||
| 546 | |a EN | ||
| 690 | |a Immunologic diseases. Allergy | ||
| 690 | |a RC581-607 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022) | |
| 787 | 0 | |n http://dx.doi.org/10.1080/21645515.2022.2073760 | |
| 787 | 0 | |n https://doaj.org/toc/2164-5515 | |
| 787 | 0 | |n https://doaj.org/toc/2164-554X | |
| 856 | 4 | 1 | |u https://doaj.org/article/8f04560e2ae24d55bbff3ccb486a93e1 |z Connect to this object online. |